Stoke Therapeutics clinical trials we track

Check company identity source

Phase 3 1 trial

Phase 2 1 trial

TrialDrugs studiedStatusPrimary completion
An Open-Label Extension Study of STK-001 for Patients With Dravet SyndromeNCT04740476zorevunersen (STK-001)Active not recruiting2029-03-31Estimated

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Safety of multiple doses of STK-001. After: Measure: Safety of multiple doses of zorevunersen.

Check registry source